IGA VASCULITIS

Clinical trials for IGA VASCULITIS explained in plain language.

Never miss a new study

Get alerted when new IGA VASCULITIS trials appear

Sign up with your email to follow new studies for IGA VASCULITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1

New hope for kids with rare kidney disease: telitacicept vs. steroids

Disease control Not yet recruiting

This study looks at whether the drug telitacicept works better than standard steroids for children aged 3-17 with kidney inflammation caused by IgA vasculitis. About 300 participants will be followed for up to 48 weeks to see if their urine protein levels drop and kidney function…

Matched conditions: IGA VASCULITIS

Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control

Last updated Jun 10, 2026 13:28 UTC

IGA VASCULITIS

Get alerted when new IGA VASCULITIS trials appear

New hope for kids with rare kidney disease: telitacicept vs. steroids